What is Mani?
Established in 1956, Mani, Inc. operates as a specialized manufacturer of high-precision medical devices, with a core competency in surgical needles and advanced wire processing technology. The company maintains a rigorous commitment to international quality standards, providing essential surgical, dental, and ophthalmic instruments to global healthcare markets. By leveraging proprietary precision engineering, Mani, Inc. bridges the gap between complex material science and clinical utility, ensuring that medical professionals have access to reliable, high-performance tools that enhance patient outcomes. Their long-standing history of technical excellence positions them as a critical supplier within the global medical supply chain.
How much funding has Mani raised?
Mani has raised a total of $89K across 1 funding round:
Debt
$89K
Debt (2024): $89K with participation from Chase
Key Investors in Mani
Chase
A global financial services firm providing comprehensive banking and investment solutions to support corporate growth and capital structure optimization.
What's next for Mani?
The infusion of $89K is strategically earmarked for operational scaling and the acceleration of R&D initiatives. As the company navigates this Series B/C stage, the focus will likely shift toward optimizing production efficiency and expanding its portfolio of ophthalmic and dental equipment. By integrating advanced automation into its manufacturing processes, Mani, Inc. aims to meet the rising global demand for high-quality surgical instruments while maintaining the stringent safety protocols that define its brand. This financial milestone provides the necessary liquidity to pursue aggressive market penetration strategies and potential technological acquisitions, ensuring the firm remains at the forefront of medical device innovation.
See full Mani company page
